Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Amson

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Nature Reviews. Cancer|January 31, 2009
The molecular programme of tumour reversion: the steps beyond malignant transformationAdam Telerman, Robert Amson
Results and Problems in Cell Differentiation|November 18, 2017
Introduction: How We Encountered TCTP and Our Purpose in Studying ItAdam Telerman, Robert Amson
Current Opinion in Oncology|November 21, 2012
Lessons from tumor reversion for cancer treatmentRobert Amson, Judith E Karp, Adam Telerman
Oncotarget|February 10, 2011
Tumor reversion holds promiseAdam Telerman, Robert Amson, Mary J C Hendrix
Immunity|August 26, 2009
Obituary: Jean DaussetAdam Telerman, Robert Amson, Peter Demant, et al.
Cell Cycle (Georgetown, Tex.)|December 31, 2010
Could TCTP contribute to Armin Braun's paradigm of tumor reversion in plants?Robert Amson, Jacek Z Kubiak, Marc Van Montagu, et al.
Results and Problems in Cell Differentiation|November 18, 2017
Targeting TCTP with Sertraline and Thioridazine in Cancer TreatmentRobert Amson, Christian Auclair, Fabrice André, et al.
Trends in Cell Biology|November 6, 2012
TPT1/ TCTP-regulated pathways in phenotypic reprogrammingRobert Amson, Salvatore Pece, Jean-Christophe Marine, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2002
Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1Marcel Tuynder, Laurent Susini, Sylvie Prieur, et al.
European Journal of Cell Biology|January 24, 2017
Acetylation of translationally controlled tumor protein promotes its degradation through chaperone-mediated autophagyAnne Bonhoure, Alice Vallentin, Marianne Martin, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Nature Reviews. Cancer|January 31, 2009
The molecular programme of tumour reversion: the steps beyond malignant transformationAdam Telerman, Robert Amson
Results and Problems in Cell Differentiation|November 18, 2017
Introduction: How We Encountered TCTP and Our Purpose in Studying ItAdam Telerman, Robert Amson
Current Opinion in Oncology|November 21, 2012
Lessons from tumor reversion for cancer treatmentRobert Amson, Judith E Karp, Adam Telerman
Oncotarget|February 10, 2011
Tumor reversion holds promiseAdam Telerman, Robert Amson, Mary J C Hendrix
Immunity|August 26, 2009
Obituary: Jean DaussetAdam Telerman, Robert Amson, Peter Demant, et al.
Cell Cycle (Georgetown, Tex.)|December 31, 2010
Could TCTP contribute to Armin Braun's paradigm of tumor reversion in plants?Robert Amson, Jacek Z Kubiak, Marc Van Montagu, et al.
Results and Problems in Cell Differentiation|November 18, 2017
Targeting TCTP with Sertraline and Thioridazine in Cancer TreatmentRobert Amson, Christian Auclair, Fabrice André, et al.
Trends in Cell Biology|November 6, 2012
TPT1/ TCTP-regulated pathways in phenotypic reprogrammingRobert Amson, Salvatore Pece, Jean-Christophe Marine, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2002
Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1Marcel Tuynder, Laurent Susini, Sylvie Prieur, et al.
European Journal of Cell Biology|January 24, 2017
Acetylation of translationally controlled tumor protein promotes its degradation through chaperone-mediated autophagyAnne Bonhoure, Alice Vallentin, Marianne Martin, et al.
Pageof 3